ClinicalTrials.Veeva

Find clinical trials for Non-Small-Cell Lung Cancer in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Non-Small-Cell Lung Cancer trials near Rochester, MN, USA:

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a

Phase 2

Daiichi Sankyo

Rochester, Minnesota, United States and 83 other locations

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Telisotuzumab vedotin

Phase 2

AbbVie
AbbVie

Rochester, Minnesota, United States and 252 other locations

combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small c ...

Active, not recruiting
Non-Small-Cell Lung Cancer
Drug: Amivantamab
Drug: Pemetrexed

Phase 1

Janssen
Janssen

Rochester, Minnesota, United States and 72 other locations

The purpose of this study is to evaluate BMS-986442 in combination with nivolumab (with or without chemotherapy) for its antitumor efficacy and benef...

Active, not recruiting
Non-small Cell Lung Cancer
Advanced Solid Tumors
Drug: Carboplatin
Biological: BMS-986442

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Rochester, Minnesota, United States and 33 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with ...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Rochester, Minnesota, United States and 22 other locations

This study will investigate the utility of biomarker-based triage for study participants with advanced non-small cell lung...

Active, not recruiting
Advanced Non-Small Cell Lung Cancer
Drug: Quavonlimab
Biological: Favezelimab

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Rochester, Minnesota, United States and 80 other locations

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small...

Enrolling
Metastatic Cancer
Advanced Cancer
Drug: avutometinib (VS-6766) and adagrasib

Phase 1, Phase 2

Verastem

Rochester, Minnesota, United States and 7 other locations

survival (OS) in treatment-naïve metastatic participants with non-small cell lung cancer (NSCLC)....

Active, not recruiting
Metastatic Non-Small Cell Lung Cancer
Biological: Pembrolizumab
Drug: Cisplatin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Rochester, Minnesota, United States and 148 other locations

This is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international study assessing the efficacy and safety of durvalumab (...

Enrolling
Non-Small Cell Lung Cancer
Drug: Domvanalimab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Rochester, Minnesota, United States and 225 other locations

deruxtecan (Dato-DXd) in combination with pembrolizumab with or without platinum chemotherapy in participants with advanced or metastatic non...

Active, not recruiting
Advanced or Metastatic NSCLC
Drug: Cisplatin
Drug: KEYTRUDA®

Phase 1

Daiichi Sankyo

Rochester, Minnesota, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems